Microprofit fluorecare® Rubella Virus IgG test kit is based on immunofluorescence assay (FIA) for quantitative detection of rubella virus IgG antibody. Fast, accurate and ideal for POCT and laboratory use.
The fluorecare® RV-IgG Test Kit (Rubella Virus IgG Antibody) developed by Microprofit is a quantitative immunofluorescence assay (FIA) designed for the accurate detection of rubella virus IgG antibody levels in human serum and plasma. Mainly used for the auxiliary diagnosis of rubella virus infection, this test kit supports efficient clinical decision-making in laboratories, hospitals, and point-of-care testing environments as part of the fluorecare® POCT diagnostic platform.
The fluorecare® RV-IgG test kit utilizes fluorescence immunochromatographic assay technology based on an indirect method. Rubella virus IgG antibody in the sample binds with fluorescent-labeled anti-human IgG to form a complex, which is captured by the coated rubella virus antigen on the test line. The fluorescence signal is positively correlated with the antibody concentration and is detected and analyzed by the fluorecare® immunofluorescence analyzer, enabling accurate and quantitative measurement.
• Auxiliary diagnosis of rubella virus infection
• Assessment of rubella immune status and vaccination response
• Pre-pregnancy and prenatal screening for rubella immunity
• Support for evaluation of congenital rubella risk
• Clinical laboratory and decentralized POCT testing
Q: What is the fluorecare® RV-IgG test kit used for?
A: The fluorecare® RV-IgG test kit is used for quantitative detection of rubella virus IgG antibody to assist in the diagnosis of rubella infection and to assess immune status, particularly for pre-pregnancy screening.
Q: How fast is the fluorecare® RV-IgG test?
A: The test provides accurate results within 15 minutes using the fluorecare® immunofluorescence analyzer.
Q: What samples can be used for this test?
A: Serum and plasma samples are suitable for testing with the fluorecare® RV-IgG test kit.
Q: Is the fluorecare® RV-IgG test suitable for POCT use?
A: Yes, it is specifically designed for point-of-care testing environments.
The fluorecare® RV-IgG test kit is specifically designed to work with the fluorecare® immunofluorescence analyzer, providing fast, accurate, and quantitative results. This integrated POCT solution ensures efficient workflow and reliable performance for laboratories, clinics, and decentralized healthcare settings.
• Quantitative detection based on immunofluorescence assay (FIA)
• Rapid results within 15 minutes
• High sensitivity and specificity
• Seamless integration with fluorecare® POCT platform
• Stable performance with internal calibration
• User-friendly operation with minimal training required
• Suitable for laboratory and point-of-care testing scenarios

REF | MF-82 | |
Product Name | Rubella Virus IgG Antibody (RV-IgG) Diagnostic Kit | |
Method | Immunochromatographic assay | |
Qualification | CE | |
Testing content | Rubella Virus IgG Antibody (RV-IgG) | |
Sample Type | Serum、plasma | |
Sample Volume(uL) | 20μL | |
Working Range | 2-300IU/ml | |
Reaction Time (min) | 15 | |
Storage Temperature | 2-30℃ | |
Shelf Life | 18 months | |
Applied Instrument | fluorecare® MF-T1000 Dry-type Immunofluorescence Quantitative Analyzer | |
Specification | 20 tests/kit | 25 tests/kit |
Size(L*W*H)mm/Kit | 145*115*75 | 205*138*83 |
Weight(kg)/Kit | 0.280 | 0.337 |
Kit components | Test Card:20 Cassettes Diluent:20 tubes ID Chip:1 Piece Instruction:1 Copy | Test Card ( including the desiccant):25 Cassettes Diluent:25 tubes ID Chip:1 Piece Instruction:1 Copy |